Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China flag China · Delayed Price · Currency is CNY
40.30
+0.32 (0.80%)
Oct 30, 2026, 3:00 PM CST

SHA:600329 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
895.672,1312,229986.71861.79769.14
Depreciation & Amortization
110.62111.32125.94130.13116.56115.53
Other Amortization
14.4113.722.273.034.112.26
Loss (Gain) From Sale of Assets
-2.83-2.83-0.11-0.15-1.08-12.32
Asset Writedown & Restructuring Costs
117.71117.71113.844.3620.161.93
Loss (Gain) From Sale of Investments
-1,646-1,646-1,908-308.11-274.22-213.49
Provision & Write-off of Bad Debts
7.417.4144.7819.099.224.89
Other Operating Activities
1,51816.5939.3938.9254.0232.68
Change in Accounts Receivable
-260.42-260.4226.2574.01-732.29-42.07
Change in Inventory
117.73117.7321.95-165.3458.87-47.4
Change in Accounts Payable
-113.1-113.1288.5-56.06609.67220.2
Change in Other Net Operating Assets
---0.02-18.986.8210.15
Operating Cash Flow
726.76461.07924.67688.49677.25852.4
Operating Cash Flow Growth
-23.29%-50.14%34.30%1.66%-20.55%26.96%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-134.23-118.61-117.81-140.93-107.9-156.95
Sale of Property, Plant & Equipment
0.160.390.080.191.4928.71
Cash Acquisitions
-----47.61-
Divestitures
---347.8---
Investment in Securities
2,770-1,310805.42-606.35-65.08-334.92
Other Investing Activities
570.2720.662.42178.18206.82151.3
Investing Cash Flow
3,207-1,408342.31-568.91-12.28-311.85

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-51,221870.86205.65-
Total Debt Issued
-51,221870.86205.65-
Long-Term Debt Repaid
--4.6-522.3-807.34-39.87-1.42
Lease Payments
-2.6-2.6-2.29-1.91-3.93-1.42
Total Debt Repaid
-4.9-4.6-522.3-807.34-39.87-1.42
Net Debt Issued (Repaid)
-4.90.4698.7763.52165.78-1.42
Repurchase of Common Stock
---0.28-22.67--1.35
Common Dividends Paid
-3,662-981.29-1,011-877.33-387.43-232.06
Other Financing Activities
-1.99--7.792.7-14.96-9.87
Financing Cash Flow
-3,669-980.88-319.89-833.77-236.62-244.7

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.02-0.22-0.040.050.01-
Net Cash Flow
263.27-1,928947.05-714.15428.35295.85

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
592.53342.45806.86547.56569.34695.45
Free Cash Flow Growth
-30.00%-57.56%47.36%-3.83%-18.13%44.21%
Free Cash Flow Margin
12.70%6.96%11.04%6.66%6.90%10.07%
Free Cash Flow Per Share
0.770.451.050.710.730.90
Levered Free Cash Flow
2,6782,0661,818360.35961.19149.46
Unlevered Free Cash Flow
2,6802,0721,843382.76967.61151.29
Free Cash Flow After Leases
589.94339.86804.57545.65565.41694.03

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
1,2101,210751.63765.94526.93496.73
Change in Working Capital
-288.14-288.14277.05-225.49-113.32151.76